Senti Biosciences is trading at $0.36 (-5.7%) as the stock extends a multi-session slide driven primarily by technical and liquidity factors.
- The downward move is attributed to ongoing selling pressure and broader risk-off sentiment currently affecting the biotechnology sector.
- There are no fresh company-specific developments, earnings reports, or regulatory updates acting as a fundamental catalyst for today's price action.